FDA Clearance Tracker · K241353
PowerLoc Max Power Injectable Infusion Set; SafeStep Huber Needle Set
Last checked: Nov 20, 2026Latest source record: Nov 27, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 27, 2024
Substantially Equivalent
Time to decision
198 days
Received May 13, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K241353
- Device name
- PowerLoc Max Power Injectable Infusion Set; SafeStep Huber Needle Set
- Applicant
- Bard Access Systems, Inc.
- Applicant location
- Salt Lake Ciy,, UT
- Received
- May 13, 2024
- Decided
- Nov 27, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Non-Coring (Huber) Needle (PTI)
- Device class
- Class II
- Regulation
- 21 CFR 880.5570
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PTI. The earliest in FDA's data is K162271, decided Apr 26, 2017.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K241353
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bard Access Systems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252478 · Decided Sep 5, 2025 · 29 days after receipt
Device type: Port & Catheter, Implanted, Subcutaneous, Intravascular (LJT) · Hospital Medicine & Nursing
K251253 · Decided Jun 18, 2025 · 56 days after receipt
Device type: Port & Catheter, Implanted, Subcutaneous, Intravascular (LJT) · Hospital Medicine & Nursing
K242328 · Decided Oct 31, 2024 · 86 days after receipt
Device type: Port & Catheter, Implanted, Subcutaneous, Intravascular (LJT) · Hospital Medicine & Nursing
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.